Cytek Biosciences Inc Financial Flexibility Index
Cytek Biosciences Inc financial flexibility index. Cytek Biosciences Inc (CTKB) has a Financial Flexibility Index of 0.00x as of March 2026. Free cash flow of $-568.00K (operating CF $-2.74 Million minus capex $2.17 Million) represents 0% of total liabilities ($121.47 Million). See Cytek Biosciences Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Cytek Biosciences Inc (2019–2025)
Financial flexibility index of Cytek Biosciences Inc from 2019 to 2025. Historical Financial Flexibility Index trend for Cytek Biosciences Inc across 7 annual periods. Check CTKB cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Cytek Biosciences Inc Financial Flexibility Index by Year (2019–2025)
Cytek Biosciences Inc financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Cytek Biosciences Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Cytek Biosciences Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.01x | $-602.00K | $-4.69 Million | $119.80 Million | ▼ -101.8% |
| 2024 | 0.28x | $28.90 Million | $25.38 Million | $103.76 Million | ▲ +179.4% |
| 2023 | 0.10x | $10.11 Million | $5.28 Million | $101.39 Million | ▲ +496.3% |
| 2022 | -0.03x | $-2.36 Million | $-12.23 Million | $93.93 Million | ▼ -116.2% |
| 2021 | 0.16x | $8.99 Million | $4.63 Million | $57.92 Million | ▲ +119.4% |
| 2020 | 0.07x | $16.70 Million | $15.16 Million | $236.01 Million | ▲ +162.1% |
| 2019 | -0.11x | $-12.77 Million | $-13.75 Million | $112.06 Million | — |